Pfizer’s Second-Quarter Results Top Street Views Boosted by COVID-19 Vaccine Sales; Raises Low End of Earnings Outlook
Pfizer recorded a 92% jump in second-quarter earnings that exceeded analysts’ expectations as the drugmaker recorded an “all-time” high in quarterly COVID-19 vaccine sales and lifted the lower end of its full-year profit outlook range. The company on Thursday posted adjusted earnings of $2.04 per share, advancing from $1.06 a Continue Reading
Israel bans use of cash for purchases larger than NIS 6,000
Cash deals exceeding 6,000 NIS will be illegal, as part of the effort to fight against money laundering and criminal activity. Under the new law, any payment to a business above 6,000 NIS ($1,700) must be made using alternative methods, such as a digital transfer or a debit card. Trading Continue Reading